{"id":4552,"date":"2026-10-07T19:38:41","date_gmt":"2026-10-07T19:38:41","guid":{"rendered":"https:\/\/nano-test.de\/?p=4552"},"modified":"2026-10-07T19:39:19","modified_gmt":"2026-10-07T19:39:19","slug":"tests-zur-markteinfuehrung-von-arzneimitteln","status":"publish","type":"post","link":"https:\/\/nano-test.de\/it\/2026\/10\/07\/tests-zur-markteinfuehrung-von-arzneimitteln\/","title":{"rendered":"Test per il lancio sul mercato dei farmaci"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"4552\" class=\"elementor elementor-4552\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-58c25262 ts-col-stretched-none ts-bg-color-over-image elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"58c25262\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-8b96c43 ts-bg-color-over-image\" data-id=\"8b96c43\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-d457181 elementor-widget elementor-widget-text-editor\" data-id=\"d457181\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<h1><span style=\"color: #000000;\">Test di approvazione del mercato dei farmaci: la base qualitativa del processo di approvazione<\/span><\/h1><p><span style=\"color: #000000;\">Lo sviluppo di un farmaco include anni di ricerca e sviluppo, nonch\u00e9 studi preclinici e clinici. Ma anche quando tutto questo lavoro \u00e8 completato, segue l'ultima e decisiva fase prima che il farmaco possa essere immesso sul mercato: il . In questo processo, i dati sulla qualit\u00e0, la sicurezza e l'efficacia presentati alle autorit\u00e0 di regolamentazione devono essere pienamente verificabili e in linea con gli standard internazionali.<\/span><\/p><p><span style=\"color: #000000;\"><strong>Die Tests zur Markteinf\u00fchrung von Arzneimitteln<\/strong> bilden die Grundlage des Qualit\u00e4tsabschnitts dieses Dokuments. Diese Tests, die in der T\u00fcrkei von der T\u0130TCK (T\u00fcrkische Arzneimittel- und Medizinproduktebeh\u00f6rde), in Europa von der EMA (Europ\u00e4ische Arzneimittelagentur) und in den USA von der FDA (Food and Drug Administration) gefordert werden, belegen die Identit\u00e4t, Reinheit, Wirksamkeit, Stabilit\u00e4t und biologische Wirksamkeit des Arzneimittels. Die Durchf\u00fchrung der Pr\u00fcfungen gem\u00e4\u00df den Grunds\u00e4tzen der GLP (Gute Laborpraxis) und der GMP (Gute Herstellungspraxis) ist f\u00fcr die Annahme des Zulassungsantrags zwingend erforderlich.<\/span><\/p><p><span style=\"color: #000000;\"><!-- H2-&#220;berschrift --><\/span><\/p><h2><span style=\"color: #000000;\">Il fascicolo tecnico congiunto (CTD) nel processo di approvazione<\/span><\/h2><p><span style=\"color: #000000;\">Zulassungsantr\u00e4ge f\u00fcr Arzneimittel werden im Rahmen der internationalen Harmonisierung im <strong>CTD-Format (Common Technical Document)<\/strong> erstellt. Das CTD besteht aus f\u00fcnf Modulen, wobei die Qualit\u00e4tsdaten in Modul 3 (Quality) enthalten sind. Die Marktzulassungstests bilden direkt den Inhalt dieses Moduls:<\/span><\/p><ul><li><span style=\"color: #000000;\"><strong>Modul 1:<\/strong> Administrative Angaben und regionale Anforderungen<\/span><\/li><li><span style=\"color: #000000;\"><strong>Modul 2:<\/strong> Zusammenfassungen zu Qualit\u00e4t, Sicherheit und Wirksamkeit (QOS, Nonclinical, Clinical)<\/span><\/li><li><span style=\"color: #000000;\"><strong>Modul 3:<\/strong> Qualit\u00e4t (chemische, pharmazeutische und biologische Daten)<\/span><\/li><li><span style=\"color: #000000;\"><strong>Modul 4:<\/strong> Berichte \u00fcber vorklinische Studien<\/span><\/li><li><span style=\"color: #000000;\"><strong>Modul 5:<\/strong> Berichte \u00fcber klinische Studien<\/span><\/li><\/ul><p><span style=\"color: #000000;\">I dati di prova presentati nel modulo 3 sono preparati separatamente per il principio attivo farmaceutico (API) e il medicinale finito. Questi dati devono essere conformi alle linee guida ICH (Q1-Q14).<\/span><\/p><p><span style=\"color: #000000;\"><!-- H2-&#220;berschrift --><\/span><\/p><h2><span style=\"color: #000000;\">Principali categorie di test di approvazione del mercato<\/span><\/h2><p><span style=\"color: #000000;\">I test necessari per l'approvazione di un medicinale possono essere suddivisi nelle seguenti categorie principali:<\/span><\/p><p><span style=\"color: #000000;\"><!-- H3-Unter&#252;berschrift --><\/span><\/p><h3><span style=\"color: #000000;\">1. Controlli di identit\u00e0 e purezza<\/span><\/h3><p><span style=\"color: #000000;\">Dimostrano che il farmaco \u00e8 il principio attivo indicato e che ha un grado accettabile di purezza. Vengono eseguiti secondo le linee guida ICH Q3A, Q3B, Q3C e Q3D.<\/span><\/p><ul><li><span style=\"color: #000000;\"><strong>Identit\u00e4t (Identity):<\/strong> Best\u00e4tigung des Wirkstoffs (API) mittels FTIR, HPLC und NMR<\/span><\/li><li><span style=\"color: #000000;\"><strong>Profilo di contaminazione:<\/strong> Impurit\u00e0 organiche, residui di solvente, metalli pesanti<\/span><\/li><li><span style=\"color: #000000;\"><strong>Enantiomere Reinheit:<\/strong> Verh\u00e4ltnis der optischen Isomere mittels chiraler HPLC<\/span><\/li><\/ul><p><span style=\"color: #000000;\"><!-- H3-Unter&#252;berschrift --><\/span><\/p><h3><span style=\"color: #000000;\">2. Determinazione dello stipendio e uniformit\u00e0 salariale<\/span><\/h3><p><span style=\"color: #000000;\">Verifica del contenuto di sostanza attiva del prodotto e della consistenza tra le singole dosi.<\/span><\/p><ul><li><span style=\"color: #000000;\"><strong>Assay (Gehaltsbestimmung):<\/strong> Bestimmung des API-Gehalts mittels HPLC<\/span><\/li><li><span style=\"color: #000000;\"><strong>Gehaltsgleichm\u00e4\u00dfigkeit (Content Uniformity):<\/strong> Gem\u00e4\u00df den Anforderungen der Pharmakop\u00f6e<\/span><\/li><li><span style=\"color: #000000;\"><strong>Aufl\u00f6sungsgeschwindigkeit (Dissolution):<\/strong> F\u00fcr feste orale Darreichungsformen<\/span><\/li><\/ul><p><span style=\"color: #000000;\"><!-- H3-Unter&#252;berschrift --><\/span><\/p><h3><span style=\"color: #000000;\">3. Prove di stabilit\u00e0 (I Q1)<\/span><\/h3><p><span style=\"color: #000000;\">Prova che il prodotto mantiene la sua qualit\u00e0 per tutta la durata.<\/span><\/p><ul><li><span style=\"color: #000000;\"><strong>Langzeitstabilit\u00e4t:<\/strong> 25 \u00b0C\/60 % r. F. oder 30 \u00b0C\/65 % r. F.<\/span><\/li><li><span style=\"color: #000000;\"><strong>Beschleunigte Stabilit\u00e4t:<\/strong> 40 \u00b0C\/75 % r. F.<\/span><\/li><li><span style=\"color: #000000;\"><strong>Zwischenstabilit\u00e4t:<\/strong> 30 \u00b0C\/65 % r. F.<\/span><\/li><li><span style=\"color: #000000;\"><strong>Stabilit\u00e0 leggera:<\/strong> I Esposizione alla luce conforme a Q1B<\/span><\/li><\/ul><p><span style=\"color: #000000;\"><!-- H3-Unter&#252;berschrift --><\/span><\/p><h3><span style=\"color: #000000;\">4. Biodisponibilit\u00e0 e bioequivalenza (I M13A)<\/span><\/h3><p><span style=\"color: #000000;\">Rileva l'equivalenza dei generici alla preparazione di riferimento.<\/span><\/p><ul><li><span style=\"color: #000000;\"><strong>Validierung bioanalytischer Methoden:<\/strong> Plasmaanalyse mittels LC-MS\/MS<\/span><\/li><li><span style=\"color: #000000;\"><strong>Pharmakokinetische Parameter:<\/strong> Cmax, AUC, Tmax<\/span><\/li><li><span style=\"color: #000000;\"><strong>Statistische \u00c4quivalenz:<\/strong> 80\u2013125 %-Kriterium bei einem 90 %-Konfidenzintervall<\/span><\/li><\/ul><p><span style=\"color: #000000;\"><!-- H3-Unter&#252;berschrift --><\/span><\/p><h3><span style=\"color: #000000;\">5. Test di qualit\u00e0 microbiologica<\/span><\/h3><p><span style=\"color: #000000;\">Vengono effettuati per prodotti sterili e prodotti per i quali sono prescritti valori limite microbiologici.<\/span><\/p><ul><li><span style=\"color: #000000;\"><strong>Test di sterilit\u00e0:<\/strong> Pharmakop\u00f6e-konform<\/span><\/li><li><span style=\"color: #000000;\"><strong>Test auf mikrobiologische Grenzwerte:<\/strong> TAMC, TYMC und Nachweis von Krankheitserregern<\/span><\/li><li><span style=\"color: #000000;\"><strong>Endotoxintest:<\/strong> LAL-Methode<\/span><\/li><\/ul><p><span style=\"color: #000000;\"><!-- Tabellenanfang --><\/span><\/p><h2><span style=\"color: #000000;\">Riepilogo dei test per il lancio del mercato e relative linee guida<\/span><\/h2><p><span style=\"color: #000000;\">La tabella seguente riassume i test di base richiesti dal processo di approvazione del farmaco e le linee guida ICH associate:<\/span><\/p><table><thead><tr><th><span style=\"color: #000000;\">Categoria di test<\/span><\/th><th><span style=\"color: #000000;\">Linee guida relative all'ego<\/span><\/th><th><span style=\"color: #000000;\">Parametro valutato<\/span><\/th><th><span style=\"color: #000000;\">Modulo CTD<\/span><\/th><\/tr><\/thead><tbody><tr><td><span style=\"color: #000000;\"><strong>Identit\u00e0 e purezza<\/strong><\/span><\/td><td><span style=\"color: #000000;\">I Q2A, Q3B, Q3C, Q3D, Q6A<\/span><\/td><td><span style=\"color: #000000;\">Identit\u00e0 del principio attivo, profilo di contaminazione, metalli pesanti<\/span><\/td><td><span style=\"color: #000000;\">Modulo 3.2.S<\/span><\/td><\/tr><tr><td><span style=\"color: #000000;\"><strong>Determinazione quantitativa<\/strong><\/span><\/td><td><span style=\"color: #000000;\">I Q2(R2), Q6a<\/span><\/td><td><span style=\"color: #000000;\">Stipendio API, uniformit\u00e0 dello stipendio, solubilit\u00e0<\/span><\/td><td><span style=\"color: #000000;\">Modulo 3.2.P<\/span><\/td><\/tr><tr><td><span style=\"color: #000000;\"><strong>Stabilit\u00e0<\/strong><\/span><\/td><td><span style=\"color: #000000;\">I Q1A(R2), Q1B, Q1E<\/span><\/td><td><span style=\"color: #000000;\">Durabilit\u00e0, profilo di degrado, stabilit\u00e0 della luce<\/span><\/td><td><span style=\"color: #000000;\">Modulo 3.2.S.7 \/ 3.2.P.8<\/span><\/td><\/tr><tr><td><span style=\"color: #000000;\"><strong>Bioequivalenza<\/strong><\/span><\/td><td><span style=\"color: #000000;\">I M13A, E6(R2)<\/span><\/td><td><span style=\"color: #000000;\">Cmax, AUC, Tmax, Equivalenza statistica<\/span><\/td><td><span style=\"color: #000000;\">Modulo 5.3.1<\/span><\/td><\/tr><tr><td><span style=\"color: #000000;\"><strong>Qualit\u00e0 microbiologica<\/strong><\/span><\/td><td><span style=\"color: #000000;\">I Q6a, Q4b<\/span><\/td><td><span style=\"color: #000000;\">Sterilit\u00e0, limiti microbiologici, endotossine<\/span><\/td><td><span style=\"color: #000000;\">Modulo 3.2.P.3<\/span><\/td><\/tr><tr><td><span style=\"color: #000000;\"><strong>Convalida analitica<\/strong><\/span><\/td><td><span style=\"color: #000000;\">I Q2(R2), Q14<\/span><\/td><td><span style=\"color: #000000;\">Precisione, precisione, specificit\u00e0, LOD\/LOQ<\/span><\/td><td><span style=\"color: #000000;\">Modulo 3.2.S.4 \/ 3.2.P.5<\/span><\/td><\/tr><\/tbody><\/table><p><span style=\"color: #000000;\"><!-- Ende der Tabelle --><\/span><\/p><p><span style=\"color: #000000;\"><!-- H2-&#220;berschrift --><\/span><\/p><h2><span style=\"color: #000000;\">Il ruolo di GLP e GMP nel processo di approvazione<\/span><\/h2><p><span style=\"color: #000000;\">La validit\u00e0 dei test di approvazione del mercato dipende non solo dall'uso di metodi analitici corretti, ma anche dal fatto che questi test vengono eseguiti in laboratori accreditati e secondo i principi GLP. GLP stabilisce regole rigide in aree come la formazione del personale, la calibrazione del dispositivo, le istruzioni di lavoro standard (SOP), l'integrit\u00e0 dei dati e l'audit trail (Audit Trail).<\/span><\/p><p><span style=\"color: #000000;\">Allo stesso modo, la conformit\u00e0 GMP del processo di produzione \u00e8 una parte inseparabile della domanda di approvazione. La compliance simultanea con GLP e GMP dimostra che il farmaco ha una qualit\u00e0 costante, sia in laboratorio che sulla scala di produzione.<\/span><\/p><div class=\"note\"><span style=\"color: #000000;\"><strong>Wichtig:<\/strong> Die in Ihrem Zulassungsantrag vorgelegten Pr\u00fcfberichte m\u00fcssen bei Inspektionen durch die Zulassungsbeh\u00f6rden vertretbar sein. Daher ist es von entscheidender Bedeutung, dass die Pr\u00fcfungen in GLP-zertifizierten Laboren durchgef\u00fchrt und die Berichte gem\u00e4\u00df den ALCOA+-Prinzipien erstellt werden.<\/span><\/div><p><span style=\"color: #000000;\"><!-- H2-&#220;berschrift: Nano-Test --><\/span><\/p><h2><span style=\"color: #000000;\">Soluzioni conformi a GLP per test di approvazione del mercato con nano-test<\/span><\/h2><p><span style=\"color: #000000;\">Der Zulassungsprozess f\u00fcr Arzneimittelhersteller erfordert eine intensive Datenaufbereitung und sorgf\u00e4ltige analytische Arbeit. <strong>Nano-Test<\/strong> ist ein GLP-akkreditierter L\u00f6sungspartner, der alle in diesem Prozess ben\u00f6tigten Qualit\u00e4tspr\u00fcfungen aus einer Hand anbietet.<\/span><\/p><div class=\"highlight\"><h3><span style=\"color: #000000;\">Nano test - Descrizione dei servizi<\/span><\/h3><p><span style=\"color: #000000;\">Nano-Test f\u00fchrt <strong>alle<\/strong> f\u00fcr den Markteinf\u00fchrungsprozess von Arzneimitteln erforderlichen Qualit\u00e4tspr\u00fcfungen in seinen GLP- und ISO\/IEC 17025-akkreditierten Laboren durch. Unser Leistungsportfolio:<\/span><\/p><ul><li><span style=\"color: #000000;\"><strong>Identit\u00e4ts- und Reinheitspr\u00fcfungen:<\/strong> API-Verifizierung und Erstellung von Verunreinigungsprofilen mittels FTIR, HPLC-DAD, LC-MS\/MS, GC-MS\/MS und ICP-MS.<\/span><\/li><li><span style=\"color: #000000;\"><strong>Quantitative Bestimmung und Gehaltseinheitlichkeit:<\/strong> Assay-, Gehaltseinheitlichkeits- und Aufl\u00f6sungspr\u00fcfungen gem\u00e4\u00df den Monografien der Pharmakop\u00f6en.<\/span><\/li><li><span style=\"color: #000000;\"><strong>Stabilit\u00e4tspr\u00fcfungen:<\/strong> Langzeit-, beschleunigte und Zwischenstabilit\u00e4tsstudien gem\u00e4\u00df ICH Q1A(R2); Photostabilit\u00e4tspr\u00fcfungen gem\u00e4\u00df ICH Q1B.<\/span><\/li><li><span style=\"color: #000000;\"><strong>Bioanalytik und Bio\u00e4quivalenz:<\/strong> Analyse von Plasmaproben mittels LC-MS\/MS, Berechnung pharmakokinetischer Parameter und statistische Bewertung der Bio\u00e4quivalenz.<\/span><\/li><li><span style=\"color: #000000;\"><strong>Qualit\u00e0 microbiologica:<\/strong> Sterilit\u00e4tstests, Tests zur Bestimmung der mikrobiellen Grenzwerte, Endotoxin-Tests (LAL) und Tests zur Wirksamkeit von Konservierungsstoffen.<\/span><\/li><li><span style=\"color: #000000;\"><strong>Convalida analitica:<\/strong> Methodenentwicklung, Validierung und Transfer gem\u00e4\u00df ICH Q2(R2) und Q14.<\/span><\/li><\/ul><p><span style=\"color: #000000;\">Alle unsere Arbeiten werden in Form von Berichten im CTD-Format vorgelegt. Die Datenintegrit\u00e4t (ALCOA+-Prinzipien) wird gew\u00e4hrleistet und ist bei Inspektionen durch die Zulassungsbeh\u00f6rden vertretbar. <strong>Es werden GLP-Konformit\u00e4tsberichte<\/strong> erstellt.<\/span><\/p><\/div><h3><span style=\"color: #000000;\">Vantaggi del nano-test nei test di lancio sul mercato:<\/span><\/h3><ul><li><span style=\"color: #000000;\"><strong>L\u00f6sung aus einer Hand:<\/strong> Alle Identit\u00e4ts-, Reinheits-, Stabilit\u00e4ts-, bioanalytischen und mikrobiologischen Pr\u00fcfungen unter einem Dach.<\/span><\/li><li><span style=\"color: #000000;\"><strong>CTD-konforme Berichterstattung:<\/strong> Berichte, die den Anforderungen von Modul 3 und Modul 5 entsprechen und von den Zulassungsbeh\u00f6rden akzeptiert werden.<\/span><\/li><li><span style=\"color: #000000;\"><strong>Verfolgung aktueller Rechtsvorschriften:<\/strong> Sofortige Anpassung an neu ver\u00f6ffentlichte Leitlinien wie ICH Q14.<\/span><\/li><li><span style=\"color: #000000;\"><strong>Hochmoderne technologische Infrastruktur:<\/strong> LC-MS\/MS, GC-MS\/MS, ICP-MS, HPLC-DAD und Klimakammern.<\/span><\/li><li><span style=\"color: #000000;\"><strong>Fachpersonal:<\/strong> Ein Team mit Erfahrung in den Bereichen pharmazeutische Analytik, Bioanalytik, Validierung und Zulassung.<\/span><\/li><li><span style=\"color: #000000;\"><strong>Schnelle Berichterstellung:<\/strong> Ergebnislieferung innerhalb von 5\u201310 Werktagen bei Standardanalysen.<\/span><\/li><\/ul><p><span style=\"color: #000000;\"><!-- H2-&#220;berschrift: Ergebnis --><\/span><\/p><p><span style=\"color: #000000;\">Il lancio sul mercato dei farmaci richiede il completamento con successo di una procedura di test completa e attenta. Identit\u00e0, purezza, stipendio, stabilit\u00e0, bioequivalenza e controlli di qualit\u00e0 microbiologici forniscono prove scientifiche sulla sicurezza, l'efficacia e la qualit\u00e0 del farmaco. Le prestazioni di questi test in laboratori accreditati in conformit\u00e0 con i principi GLP e il reporting completo in formato CTD sono un prerequisito per accettare la tua domanda di approvazione.<\/span><\/p><p><span style=\"color: #000000;\">Con la sua infrastruttura accreditata GLP, le tecnologie analitiche avanzate e i suoi professionisti, Nano-Test soddisfa pienamente i requisiti dei produttori di farmaci per i test di approvazione del mercato. Collabora con Nano-Test per accelerare la tua domanda di ammissione e soddisfare i requisiti delle autorit\u00e0 di regolamentazione.<\/span><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Marktzulassungstests f\u00fcr Arzneimittel: Die qualitative Grundlage des Zulassungsverfahrens Die Entwicklung eines Arzneimittels umfasst jahrelange Forschungs- und Entwicklungsarbeiten sowie pr\u00e4klinische und klinische Studien. Doch selbst wenn all diese Arbeiten abgeschlossen sind, folgt noch die letzte und entscheidende Phase, bevor das Arzneimittel auf den Markt gebracht werden kann: der . In diesem Prozess m\u00fcssen die den Zulassungsbeh\u00f6rden \u2026 <a href=\"https:\/\/nano-test.de\/it\/2026\/10\/07\/tests-zur-markteinfuehrung-von-arzneimitteln\/\" class=\"more-link\" title=\"Continue reading &lt;span class=\" screen-reader-text>Tests zur Markteinf\u00fchrung von Arzneimitteln\u201c&gt;Continue reading <span class=\"screen-reader-text\">Test per il lancio sul mercato dei farmaci<\/span><\/a><\/p>\n","protected":false},"author":4,"featured_media":4553,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-4552","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharma-blog"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Tests zur Markteinf\u00fchrung von Arzneimitteln | Nano-Test\u00ae<\/title>\n<meta name=\"description\" content=\"F\u00fcr die Markteinf\u00fchrung von Arzneimitteln erforderliche Pr\u00fcfungen: Stabilit\u00e4t, Bio\u00e4quivalenz, analytische Validierung, mikrobiologische Qualit\u00e4t und Anforderungen an das CTD-Dossier\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nano-test.de\/2026\/10\/07\/tests-zur-markteinfuehrung-von-arzneimitteln\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tests zur Markteinf\u00fchrung von Arzneimitteln | Nano-Test\u00ae\" \/>\n<meta property=\"og:description\" content=\"F\u00fcr die Markteinf\u00fchrung von Arzneimitteln erforderliche Pr\u00fcfungen: Stabilit\u00e4t, Bio\u00e4quivalenz, analytische Validierung, mikrobiologische Qualit\u00e4t und Anforderungen an das CTD-Dossier\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nano-test.de\/2026\/10\/07\/tests-zur-markteinfuehrung-von-arzneimitteln\/\" \/>\n<meta property=\"og:site_name\" content=\"Nano-Test\u00ae\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-07T19:38:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-07T19:39:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nano-test.de\/wp-content\/uploads\/2026\/10\/Tests-zur-Markteinfuehrung-von-Arzneimitteln.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"750\" \/>\n\t<meta property=\"og:image:height\" content=\"450\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Sultan Culum\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sultan Culum\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nano-test.de\\\/2026\\\/10\\\/07\\\/tests-zur-markteinfuehrung-von-arzneimitteln\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nano-test.de\\\/2026\\\/10\\\/07\\\/tests-zur-markteinfuehrung-von-arzneimitteln\\\/\"},\"author\":{\"name\":\"Sultan Culum\",\"@id\":\"https:\\\/\\\/nano-test.de\\\/#\\\/schema\\\/person\\\/e873a4aee4023b424d94f10e41a12670\"},\"headline\":\"Tests zur Markteinf\u00fchrung von Arzneimitteln\",\"datePublished\":\"2026-10-07T19:38:41+00:00\",\"dateModified\":\"2026-10-07T19:39:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nano-test.de\\\/2026\\\/10\\\/07\\\/tests-zur-markteinfuehrung-von-arzneimitteln\\\/\"},\"wordCount\":1214,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nano-test.de\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nano-test.de\\\/2026\\\/10\\\/07\\\/tests-zur-markteinfuehrung-von-arzneimitteln\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nano-test.de\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Tests-zur-Markteinfuehrung-von-Arzneimitteln.webp\",\"articleSection\":[\"Pharma\"],\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nano-test.de\\\/2026\\\/10\\\/07\\\/tests-zur-markteinfuehrung-von-arzneimitteln\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nano-test.de\\\/2026\\\/10\\\/07\\\/tests-zur-markteinfuehrung-von-arzneimitteln\\\/\",\"url\":\"https:\\\/\\\/nano-test.de\\\/2026\\\/10\\\/07\\\/tests-zur-markteinfuehrung-von-arzneimitteln\\\/\",\"name\":\"Tests zur Markteinf\u00fchrung von Arzneimitteln | Nano-Test\u00ae\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nano-test.de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nano-test.de\\\/2026\\\/10\\\/07\\\/tests-zur-markteinfuehrung-von-arzneimitteln\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nano-test.de\\\/2026\\\/10\\\/07\\\/tests-zur-markteinfuehrung-von-arzneimitteln\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nano-test.de\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Tests-zur-Markteinfuehrung-von-Arzneimitteln.webp\",\"datePublished\":\"2026-10-07T19:38:41+00:00\",\"dateModified\":\"2026-10-07T19:39:19+00:00\",\"description\":\"F\u00fcr die Markteinf\u00fchrung von Arzneimitteln erforderliche Pr\u00fcfungen: Stabilit\u00e4t, Bio\u00e4quivalenz, analytische Validierung, mikrobiologische Qualit\u00e4t und Anforderungen an das CTD-Dossier\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nano-test.de\\\/2026\\\/10\\\/07\\\/tests-zur-markteinfuehrung-von-arzneimitteln\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nano-test.de\\\/2026\\\/10\\\/07\\\/tests-zur-markteinfuehrung-von-arzneimitteln\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/nano-test.de\\\/2026\\\/10\\\/07\\\/tests-zur-markteinfuehrung-von-arzneimitteln\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nano-test.de\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Tests-zur-Markteinfuehrung-von-Arzneimitteln.webp\",\"contentUrl\":\"https:\\\/\\\/nano-test.de\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/Tests-zur-Markteinfuehrung-von-Arzneimitteln.webp\",\"width\":750,\"height\":450},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nano-test.de\\\/2026\\\/10\\\/07\\\/tests-zur-markteinfuehrung-von-arzneimitteln\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nano-test.de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tests zur Markteinf\u00fchrung von Arzneimitteln\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nano-test.de\\\/#website\",\"url\":\"https:\\\/\\\/nano-test.de\\\/\",\"name\":\"NANO-TEST\u00ae\",\"description\":\"Laboranalysen, Testservices, Pr\u00fcflabor &amp; Qualit\u00e4tskontrollen in Deutschland\",\"publisher\":{\"@id\":\"https:\\\/\\\/nano-test.de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nano-test.de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nano-test.de\\\/#organization\",\"name\":\"NANO-TEST\u00ae\",\"url\":\"https:\\\/\\\/nano-test.de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/nano-test.de\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nano-test.de\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Nanotest-Logo-NT-scaled.png\",\"contentUrl\":\"https:\\\/\\\/nano-test.de\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/Nanotest-Logo-NT-scaled.png\",\"width\":2510,\"height\":2560,\"caption\":\"NANO-TEST\u00ae\"},\"image\":{\"@id\":\"https:\\\/\\\/nano-test.de\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nano-test.de\\\/#\\\/schema\\\/person\\\/e873a4aee4023b424d94f10e41a12670\",\"name\":\"Sultan Culum\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ef47288e2a0dc3ff55e71e172f39c9c82ffbf55bad226f89d1aaa823e517a73b?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ef47288e2a0dc3ff55e71e172f39c9c82ffbf55bad226f89d1aaa823e517a73b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ef47288e2a0dc3ff55e71e172f39c9c82ffbf55bad226f89d1aaa823e517a73b?s=96&d=mm&r=g\",\"caption\":\"Sultan Culum\"},\"sameAs\":[\"https:\\\/\\\/nano-test.de\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Test di lancio sul mercato della droga | Nano-test\u00ae","description":"Test necessari per il lancio sul mercato dei farmaci: stabilit\u00e0, bioequivalenza, convalida analitica, qualit\u00e0 microbiologica e requisiti per il dossier CTD","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nano-test.de\/2026\/10\/07\/tests-zur-markteinfuehrung-von-arzneimitteln\/","og_locale":"it_IT","og_type":"article","og_title":"Tests zur Markteinf\u00fchrung von Arzneimitteln | Nano-Test\u00ae","og_description":"F\u00fcr die Markteinf\u00fchrung von Arzneimitteln erforderliche Pr\u00fcfungen: Stabilit\u00e4t, Bio\u00e4quivalenz, analytische Validierung, mikrobiologische Qualit\u00e4t und Anforderungen an das CTD-Dossier","og_url":"https:\/\/nano-test.de\/it\/2026\/10\/07\/tests-zur-markteinfuehrung-von-arzneimitteln\/","og_site_name":"Nano-Test\u00ae","article_published_time":"2026-10-07T19:38:41+00:00","article_modified_time":"2026-10-07T19:39:19+00:00","og_image":[{"width":750,"height":450,"url":"https:\/\/nano-test.de\/wp-content\/uploads\/2026\/10\/Tests-zur-Markteinfuehrung-von-Arzneimitteln.webp","type":"image\/webp"}],"author":"Sultan Culum","twitter_card":"summary_large_image","twitter_misc":{"Scritto da":"Sultan Culum","Tempo di lettura stimato":"6 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nano-test.de\/2026\/10\/07\/tests-zur-markteinfuehrung-von-arzneimitteln\/#article","isPartOf":{"@id":"https:\/\/nano-test.de\/2026\/10\/07\/tests-zur-markteinfuehrung-von-arzneimitteln\/"},"author":{"name":"Sultano Culum","@id":"https:\/\/nano-test.de\/#\/schema\/person\/e873a4aee4023b424d94f10e41a12670"},"headline":"Tests zur Markteinf\u00fchrung von Arzneimitteln","datePublished":"2026-10-07T19:38:41+00:00","dateModified":"2026-10-07T19:39:19+00:00","mainEntityOfPage":{"@id":"https:\/\/nano-test.de\/2026\/10\/07\/tests-zur-markteinfuehrung-von-arzneimitteln\/"},"wordCount":1214,"commentCount":0,"publisher":{"@id":"https:\/\/nano-test.de\/#organization"},"image":{"@id":"https:\/\/nano-test.de\/2026\/10\/07\/tests-zur-markteinfuehrung-von-arzneimitteln\/#primaryimage"},"thumbnailUrl":"https:\/\/nano-test.de\/wp-content\/uploads\/2026\/10\/Tests-zur-Markteinfuehrung-von-Arzneimitteln.webp","articleSection":["Pharma"],"inLanguage":"it-IT","potentialAction":[{"@type":"CommentAction","name":"Commento","target":["https:\/\/nano-test.de\/2026\/10\/07\/tests-zur-markteinfuehrung-von-arzneimitteln\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nano-test.de\/2026\/10\/07\/tests-zur-markteinfuehrung-von-arzneimitteln\/","url":"https:\/\/nano-test.de\/2026\/10\/07\/tests-zur-markteinfuehrung-von-arzneimitteln\/","name":"Test di lancio sul mercato della droga | Nano-test\u00ae","isPartOf":{"@id":"https:\/\/nano-test.de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nano-test.de\/2026\/10\/07\/tests-zur-markteinfuehrung-von-arzneimitteln\/#primaryimage"},"image":{"@id":"https:\/\/nano-test.de\/2026\/10\/07\/tests-zur-markteinfuehrung-von-arzneimitteln\/#primaryimage"},"thumbnailUrl":"https:\/\/nano-test.de\/wp-content\/uploads\/2026\/10\/Tests-zur-Markteinfuehrung-von-Arzneimitteln.webp","datePublished":"2026-10-07T19:38:41+00:00","dateModified":"2026-10-07T19:39:19+00:00","description":"Test necessari per il lancio sul mercato dei farmaci: stabilit\u00e0, bioequivalenza, convalida analitica, qualit\u00e0 microbiologica e requisiti per il dossier CTD","breadcrumb":{"@id":"https:\/\/nano-test.de\/2026\/10\/07\/tests-zur-markteinfuehrung-von-arzneimitteln\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nano-test.de\/2026\/10\/07\/tests-zur-markteinfuehrung-von-arzneimitteln\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/nano-test.de\/2026\/10\/07\/tests-zur-markteinfuehrung-von-arzneimitteln\/#primaryimage","url":"https:\/\/nano-test.de\/wp-content\/uploads\/2026\/10\/Tests-zur-Markteinfuehrung-von-Arzneimitteln.webp","contentUrl":"https:\/\/nano-test.de\/wp-content\/uploads\/2026\/10\/Tests-zur-Markteinfuehrung-von-Arzneimitteln.webp","width":750,"height":450},{"@type":"BreadcrumbList","@id":"https:\/\/nano-test.de\/2026\/10\/07\/tests-zur-markteinfuehrung-von-arzneimitteln\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Casa","item":"https:\/\/nano-test.de\/"},{"@type":"ListItem","position":2,"name":"Test per il lancio sul mercato dei farmaci"}]},{"@type":"WebSite","@id":"https:\/\/nano-test.de\/#website","url":"https:\/\/nano-test.de\/","name":"Nano-test\u00ae","description":"Analisi di laboratorio, servizi di test, laboratorio di prova eamp; Controlli di qualit\u00e0 in Germania","publisher":{"@id":"https:\/\/nano-test.de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nano-test.de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/nano-test.de\/#organization","name":"Nano-test\u00ae","url":"https:\/\/nano-test.de\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/nano-test.de\/#\/schema\/logo\/image\/","url":"https:\/\/nano-test.de\/wp-content\/uploads\/2026\/03\/Nanotest-Logo-NT-scaled.png","contentUrl":"https:\/\/nano-test.de\/wp-content\/uploads\/2026\/03\/Nanotest-Logo-NT-scaled.png","width":2510,"height":2560,"caption":"Nano-test\u00ae"},"image":{"@id":"https:\/\/nano-test.de\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nano-test.de\/#\/schema\/person\/e873a4aee4023b424d94f10e41a12670","name":"Sultano Culum","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/secure.gravatar.com\/avatar\/ef47288e2a0dc3ff55e71e172f39c9c82ffbf55bad226f89d1aaa823e517a73b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ef47288e2a0dc3ff55e71e172f39c9c82ffbf55bad226f89d1aaa823e517a73b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ef47288e2a0dc3ff55e71e172f39c9c82ffbf55bad226f89d1aaa823e517a73b?s=96&d=mm&r=g","caption":"Sultano Culum"},"sameAs":["https:\/\/nano-test.de"]}]}},"_links":{"self":[{"href":"https:\/\/nano-test.de\/wp-json\/wp\/v2\/posts\/4552","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nano-test.de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nano-test.de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nano-test.de\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/nano-test.de\/wp-json\/wp\/v2\/comments?post=4552"}],"version-history":[{"count":0,"href":"https:\/\/nano-test.de\/wp-json\/wp\/v2\/posts\/4552\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nano-test.de\/wp-json\/wp\/v2\/media\/4553"}],"wp:attachment":[{"href":"https:\/\/nano-test.de\/wp-json\/wp\/v2\/media?parent=4552"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nano-test.de\/wp-json\/wp\/v2\/categories?post=4552"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nano-test.de\/wp-json\/wp\/v2\/tags?post=4552"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}